Literature DB >> 16766748

Cellular immune responses against persistent hepatitis C virus: gone but not forgotten.

P Klenerman1, N Semmo.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16766748      PMCID： PMC1856310          DOI： 10.1136/gut.2005.087304

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  29 in total

Review 1.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection.

Authors:  A M Grabowska; F Lechner; P Klenerman; P J Tighe; S Ryder; J K Ball; B J Thomson; W L Irving; R A Robins
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

3.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.

Authors:  M Thursz; R Yallop; R Goldin; C Trepo; H C Thomas
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

4.  Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.

Authors:  Georg M Lauer; Kei Ouchi; Raymond T Chung; Tam N Nguyen; Cheryl L Day; Deborah R Purkis; Markus Reiser; Arthur Y Kim; Michaela Lucas; Paul Klenerman; Bruce D Walker
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

6.  Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Authors:  Heiner Wedemeyer; Xiao-Song He; Michelina Nascimbeni; Anthony R Davis; Harry B Greenberg; Jay H Hoofnagle; T Jake Liang; Harvey Alter; Barbara Rehermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

7.  Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.

Authors:  Ulf Dittmer; Hong He; Ronald J Messer; Simone Schimmer; Anke R M Olbrich; Claes Ohlen; Philip D Greenberg; Ingunn M Stromnes; Michihiro Iwashiro; Shimon Sakaguchi; Leonard H Evans; Karin E Peterson; Guojun Yang; Kim J Hasenkrug
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

8.  Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.

Authors:  Kazushi Sugimoto; Fusao Ikeda; Jason Stadanlick; Frederick A Nunes; Harvey J Alter; Kyong-Mi Chang
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

9.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.

Authors:  A L Erickson; Y Kimura; S Igarashi; J Eichelberger; M Houghton; J Sidney; D McKinney; A Sette; A L Hughes; C M Walker
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

10.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307
View more
  1 in total

1.  Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake.

Authors:  Polyxeni P Doumba; Elisavet Serti; Maria Boutsikou; Manousos M Konstadoulakis; Urania Georgopoulou; John Koskinas
Journal:  Cell Mol Life Sci       Date:  2013-05-05       Impact factor: 9.261
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.